Lodoxamide - CISMeF

Preferred Label : Lodoxamide;

NCIt definition : A synthetic mast cell stabilizing compound with anti-inflammatory activity. Lodoxamide appears to inhibit the antigen-stimulated calcium transport across the mast cell membrane, thereby inhibiting mast cell degranulation and the release of histamine, leukotrienes, and other substances that cause hypersensitivity reactions. Lodoxamide also inhibits eosinophil chemotaxis. When applied topically to the eye, this drug prevents the symptoms associated with keratitis or conjunctivitis.;

UNII : SPU695OD73;

InChIKey : RVGLGHVJXCETIO-UHFFFAOYSA-N;

CAS number : 53882-12-5;

Chemical formula : C11H6ClN3O6;

Details

Origin ID

C61813;

UMLS CUI

C0126120;

Automatic exact mappings (from CISMeF team)
- Product containing lodoxamide (medicinal product) [SNOMED CT concept]
- lodoxamide ethyl [MeSH Supplementary Concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Lodoxamide (substance) [SNOMED CT concept]
- Product containing lodoxamide (medicinal product) [SNOMED CT concept]
- lodoxamide [ATC Code]
- lodoxamide [MeSH concept]
Validated automatic mappings to BTNT
- lodoxamide [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
has_salt_form
- Lodoxamide Tromethamine [NCIt concept]
is_free_acid_or_base_form_of
- Lodoxamide Tromethamine [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients